Comparison of clinical prediction scores for severe ADAMTS13 deficiency
. | PLASMIC score . | French score, points . | Bentley score, points . | |
---|---|---|---|---|
Component of score | ||||
Platelet count | <30 × 109/L: 1 point | ≤30 × 109/L: 1 point | >35 × 109/L:−30 points | |
Creatinine level | <2 mg/dL: 1 point | ≤2.26 mg/dL: 1 point | >2 mg/dL:−11.5 points | |
Parameters of hemolysis | Reticulocyte count >2.5%: 1 point | — | Reticulocyte: >3% +21 points | |
Indirect bilirubin >1.5 mg/dL:+20.5 points | ||||
Haptoglobin undetectable: 1 point | ||||
Indirect bilirubin >2 mg/dL: 1 point | ||||
Associated conditions | No active cancer: 1 point | — | — | |
No history of solid-organ or hematopoietic stem cell transplant: 1 point | ||||
MCV | <90 fL: 1 point | — | — | |
INR | <1.5: 1 point | — | — | |
ANA | — | Positive: 1 point | — | |
d-dimer | — | — | >4 mcg/mL:−10 points | |
Interpretation | ||||
Risk category, total score | ||||
Low | 0-4 | 0 | <20 | |
Intermediate | 5 | 1 | 20-30 | |
High | 6-7 | 2-3 | >30 |
. | PLASMIC score . | French score, points . | Bentley score, points . | |
---|---|---|---|---|
Component of score | ||||
Platelet count | <30 × 109/L: 1 point | ≤30 × 109/L: 1 point | >35 × 109/L:−30 points | |
Creatinine level | <2 mg/dL: 1 point | ≤2.26 mg/dL: 1 point | >2 mg/dL:−11.5 points | |
Parameters of hemolysis | Reticulocyte count >2.5%: 1 point | — | Reticulocyte: >3% +21 points | |
Indirect bilirubin >1.5 mg/dL:+20.5 points | ||||
Haptoglobin undetectable: 1 point | ||||
Indirect bilirubin >2 mg/dL: 1 point | ||||
Associated conditions | No active cancer: 1 point | — | — | |
No history of solid-organ or hematopoietic stem cell transplant: 1 point | ||||
MCV | <90 fL: 1 point | — | — | |
INR | <1.5: 1 point | — | — | |
ANA | — | Positive: 1 point | — | |
d-dimer | — | — | >4 mcg/mL:−10 points | |
Interpretation | ||||
Risk category, total score | ||||
Low | 0-4 | 0 | <20 | |
Intermediate | 5 | 1 | 20-30 | |
High | 6-7 | 2-3 | >30 |